Printer Friendly

NIDA CERTIFIES PRECISION DRUG-TESTING LABORATORY OF AMERICA

       NIDA CERTIFIES PRECISION DRUG-TESTING LABORATORY OF AMERICA
    SOUTH PLAINFIELD, N.J., Feb. 11 /PRNewswire/ -- Princeton Diagnostic Laboratories of America, Inc. (AMEX: PDA) announced today that its Mississippi subsidiary, Precision Drug-testing Laboratory of America, Inc., has been certified by the National Institute on Drug Abuse (NIDA).
    NIDA certifies laboratories meeting strict standards for Federal Workplace Drug Testing Programs, which means that Precision now has the highest certification for a drug testing laboratory and can now bid for government drug testing contracts.
    Carlton E. Turner, president and CEO of PDLA, said, "PDLA now has two NIDA-certified laboratories located around transportation hubs. Precision is in close proximity to Federal Express in Memphis and will give us greater flexibility and enhance our sales effort."
    PDLA provides drug testing for pre-employment and is authorized to provide drug testing services to government agencies and businesses regulated by the U.S. Department of Transportation, contractors for the Department of Defense and other industries subject to federal drug testing guidelines.
    In addition to NIDA certification, PDLA is certified by the College of American Pathologists (CAP) and licensed by various states and federal agencies.
    Information on drug testing services by PDLA may be obtained by calling 800-237-PDLA or 601-236-5600.
    -0-                  2/11/92
    /CONTACT:  Carlton Turner of PDLA, 800-237-7352/
    (PDA) CO:  Princeton Diagnostic Laboratories of America Inc. ST:  New Jersey IN:  HEA SU: SM-CK -- NY022 -- 8708 02/11/92 10:22 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1992
Words:233
Previous Article:NETWORK WORLD ANNOUNCES FRAME RELAY TESTING
Next Article:IBM ANNOUNCES NEW ES/9000 AIR-COOLED MODELS; NEW PROCESSORS MEET NEED FOR SMALLER SYSTEMS
Topics:


Related Articles
NIDA CERTIFIES PRECISION DRUG-TESTING LABORATORIES OF AMERICA
A guide to NIDA certification for workplace drug testing.
PRINCETON DIAGNOSTIC LABORATORIES REPORTS RESULTS
SMITHKLINE BEECHAM DRUG TESTING INDEX SHOWS HIGH POSITIVE POST-ACCIDENT DRUG TESTS
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. MARKETS DRUG TESTING PROGRAM
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. APPOINTS MCBEE VP
U.S. DRUG TESTING SUBMITS 510K APPLICATION TO FDA
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA ANNOUNCES SALE OF FACILITY
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. SHAREHOLDERS APPROVE MERGER WITH EDITEK, INC.
MICHAEL TERRETTI JOINS PDLA, INC. AS VICE PRESIDENT AND GENERAL MANAGER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters